Park Medi World has announced that its management will participate in a group investor meeting organized by PhillipCapital (India) Pvt. Ltd. The event is scheduled to take place in Mumbai on June 23, 2026, from 2:00 p.m. to 05:00 p.m. The company confirmed that no unpublished price-sensitive information will be discussed during the interaction.

The disclosure was made to the exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, titled "Phillip Capital PCG-INDIA Inc. Unplugged: Conversations that Create Conviction," will be conducted in person. The schedule is subject to changes due to exigencies on the part of investors or the company.

Meeting Details

The company stated that the representative attending the meeting does not intend to disclose any unpublished price-sensitive information. The disclosure is also available on the company's website.

Park Medi World Limited announced on June 05, 2026, that its wholly owned subsidiary, Aggarwal Hospital and Research Services Private Limited, has divested its entire 55% shareholding in Devina Derma Private Limited for a consideration of INR 0.06 crore. The strategic move, part of the group's restructuring initiatives, was undertaken due to the sellers' failure to fulfil certain pre-requisite conditions stipulated under transactional documents, which posed a risk to operational efficiency and financial flexibility. Upon completion of the sale, Devina Derma Private Limited has ceased to be a subsidiary of Aggarwal Hospital and Research Services Private Limited and, consequently, of Park Medi World Limited.

The divestment was approved by the Board of Directors of Aggarwal Hospital and Research Services Private Limited. Management views the decision as prudent and value-accretive, allowing the group to streamline its corporate structure and focus resources on core strategic priorities. The buyer, Zen Zone Healthcare Private Limited, is not part of the promoter or promoter group of Park Medi World Limited.

The transaction details were disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated January 30, 2026. The agreement for sale was entered into on June 05, 2026, with the sale concluding on the same day.

Financial disclosures regarding the divested entity indicate that Devina Derma Private Limited recorded a turnover of Rs. 0.45 crores for the financial year ended March 31, 2026. This constituted approximately 0.03% of the consolidated turnover of Park Medi World Limited. Additionally, the subsidiary had a negative net worth of INR (0.34).

The following table outlines the key details of the transaction as per the regulatory filing:

Park Medi World Limited stated that it remains committed to enhancing long-term stakeholder value and strengthening its competitive positioning through such strategic initiatives. The group continues to evaluate measures to sustain growth momentum across its operational footprint.